Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT Recommendations

The Journal of Pain - Tập 9 - Trang 105-121 - 2008
Robert H. Dworkin1, Dennis C. Turk2, Kathleen W. Wyrwich3, Dorcas Beaton4, Charles S. Cleeland5, John T. Farrar6, Jennifer A. Haythornthwaite7, Mark P. Jensen2, Robert D. Kerns8, Deborah N. Ader9, Nancy Brandenburg10, Laurie B. Burke11, David Cella12, Julie Chandler13, Penny Cowan14, Rozalina Dimitrova15, Raymond Dionne16, Sharon Hertz11, Alejandro R. Jadad17, Nathaniel P. Katz18
1Departments of Anesthesiology and Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York
2University of Washington, Seattle, Washington
3Saint Louis University, St Louis, Missouri
4Institute for Work and Health, University of Toronto, Toronto, Canada
5M.D. Anderson Cancer Center, Houston, Texas
6University of Pennsylvania, Philadelphia, Pennsylvania
7Johns Hopkins University, Baltimore, Maryland
8VA Connecticut Healthcare System and Yale University, West Haven, Connecticut.
9National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland.
10Pfizer Inc, New York, New York
11United States Food and Drug Administration, Rockville, Maryland
12Evanston Northwestern Healthcare and Northwestern University, Evanston, Illinois.
13Merck & Company, Blue Bell, Pennsylvania.
14American Chronic Pain Association, Rocklin, California.
15Allergan, Inc, Irvine, California
16National Institute of Nursing Research, Bethesda, Maryland.
17University Health Network and University of Toronto, Toronto, Canada
18Analgesic Research, Needham, Massachusetts

Tài liệu tham khảo

Acquadro, 2003, Incorporating the patient’s perspective into drug development and communication: An ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization group Meeting at the Food and Drug Administration, February 16, 2001, Value Health, 6, 522, 10.1046/j.1524-4733.2003.65309.x Altmaier, 1992, The effectiveness of psychological interventions for the rehabilitation of low back pain: A randomized controlled trial evaluation, Pain, 49, 329, 10.1016/0304-3959(92)90240-C Anastasi, 1997 Anderson, 2005, Role of cutpoints: Why grade pain intensity?, Pain, 113, 5, 10.1016/j.pain.2004.10.024 Anderson, 2001, How to assess cancer pain, 579 Atkinson, 1998, A placebo-controlled randomized clinical trial of nortriptyline for chronic low back pain, Pain, 76, 287, 10.1016/S0304-3959(98)00064-5 Beaton, 2000, Understanding the relevance of measured change through studies of responsiveness, Spine, 25, 3192, 10.1097/00007632-200012150-00015 Beaton, 2001, Looking for important change/differences in studies of responsiveness, J Rheumatol, 28, 400 Beck, 1993 Beck, 1961, An inventory for measuring depression, Arch Gen Psychiatry, 4, 561, 10.1001/archpsyc.1961.01710120031004 Beilin, 2003, The numeric rating scale and labor epidural analgesia, Anesth Analg, 96, 1794, 10.1213/01.ANE.0000061581.23351.29 Bellamy, 1988, Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee, J Rheumatol, 15, 1833 Bellamy, 1992, Osteoarthritis antirheumatic drug trials, III: Setting the delta for clinical trials—results of a consensus development (Delphi) exercise, J Rheumatol, 19, 451 Bellamy, 2001, Towards a definition of “difference” in osteoarthritis, J Rheumatol, 28, 427 Bergstrom, 1999, A psychometric evaluation of the Swedish version of the Multidimensional Pain Inventory (MPI-S): A gender differentiation evaluation, Eur J Pain, 3, 261, 10.1016/S1090-3801(99)90053-8 Bernstein, 1995, On the utility of the West Haven-Yale Multidimensional Pain Inventory, Spine, 8, 956, 10.1097/00007632-199504150-00014 Bird, 2001, Clinically significant changes in pain along the visual analog scale, Ann Emerg Med, 38, 639, 10.1067/mem.2001.118012 Bombardier, 2001, Minimal clinically important difference: Low back pain: Outcome measures, J Rheumatol, 28, 431 Cella, 2002, Group vs individual approaches to understanding the clinical significance of differences or changes in quality of life, Mayo Clin Proc, 77, 384, 10.4065/77.4.384 Cella, 2002, What is clinically meaningful change on the Functional Assessment of Cancer Therapy–Lung (FACT-L) Questionnaire?, J Clin Epidemiol, 55, 285, 10.1016/S0895-4356(01)00477-2 Cella, 2002, Meaningful change in cancer-specific quality of life scores: Differences between improvement and worsening, Qual Life Res, 11, 207, 10.1023/A:1015276414526 Cella, 2002, Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) Anemia and Fatigue Scales, J Pain Symptom Manage, 24, 547, 10.1016/S0885-3924(02)00529-8 Cepeda, 2003, What decline in pain intensity is meaningful to patients with acute pain?, Pain, 105, 151, 10.1016/S0304-3959(03)00176-3 Cleeland Cleeland, 1996, Dimensions of the impact of cancer pain in a four country sample: New information from multidimensional scaling, Pain, 67, 267, 10.1016/0304-3959(96)03131-4 Cleeland, 1994, Pain assessment: Global use of the Brief Pain Inventory, Ann Acad Med, 23, 129 Clinch, 2001, Individualized functional priority approach to the assessment of health related quality of life in rheumatology, J Rheumatol, 28, 445 Cohen, 1988 Crosby, 2003, Defining clinically meaningful change in health-related quality of life, J Clin Epidemiol, 56, 395, 10.1016/S0895-4356(03)00044-1 Crosby, 2004, An integrated method to determine meaningful changes in health-related quality of life, J Clin Epidemiol, 57, 1153, 10.1016/j.jclinepi.2004.04.004 Curran, 1995, Short Form of the Profile of Mood States (POMS-SF): Psychometric information, Psychol Assess, 7, 80, 10.1037/1040-3590.7.1.80 de Vet, 2006, Minimal changes in health status questionnaires: distinction between minimally detectable change and minimally important change, Health Qual Life Outcomes, 4, 54, 10.1186/1477-7525-4-54 Dworkin, 2003, Pregabalin for the treatment of postherpetic neuralgia: A randomized, placebo-controlled trial, Neurology, 60, 1274, 10.1212/01.WNL.0000055433.55136.55 Dworkin, 2005, Core outcome measures for chronic pain clinical trials: IMMPACT recommendations, Pain, 113, 9, 10.1016/j.pain.2004.09.012 Edwards, 2004, Mood swings: Variability in the use of the Profile of Mood States, J Pain Symptom Manage, 28, 534, 10.1016/j.jpainsymman.2004.10.004 Endler, 2003, Coping with chronic pain, Pers Indiv Differences, 34, 323, 10.1016/S0191-8869(02)00048-X Eton, 2004, A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four end points in a breast cancer scale, J Clin Epidemiol, 57, 898, 10.1016/j.jclinepi.2004.01.012 Fairbank, 1980, The Oswestry Low Back Pain Disability Questionnaire, Physiotherapy, 66, 271 Farrar Farrar, 2003, Clinically important changes in acute pain outcome measures: A validation study, J Pain Symptom Manage, 25, 406, 10.1016/S0885-3924(03)00162-3 Farrar, 2006, Use of the cumulative proportion of responders analysis graph to present pain data over a range of cut-off points: Making clinical trial data more understandable, J Pain Symptom Manage, 31, 369, 10.1016/j.jpainsymman.2005.08.018 Farrar, 2000, Defining the clinically important difference in pain outcome measures, Pain, 88, 287, 10.1016/S0304-3959(00)00339-0 Farrar, 2001, Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale, Pain, 94, 149, 10.1016/S0304-3959(01)00349-9 Ferrari, 2000, Internal structure and validity of the Multidimensional Pain Inventory, Italian language version, Pain Med, 1, 123, 10.1046/j.1526-4637.2000.00020.x Finnerup, 2005, Algorithm for neuropathic pain treatment: An evidence based proposal, Pain, 118, 289, 10.1016/j.pain.2005.08.013 Fischer, 1999, Capturing the patient’s view of change as a clinical outcome measure, JAMA, 282, 1157, 10.1001/jama.282.12.1157 Flor, 1990, Zur anwendbarkeit des West Haven-Yale Multidimensional Pain Inventory im Deutschen sprachraum, Der Schmerz, 4, 82, 10.1007/BF02527839 Forouzanfar, 2003, What is a meaningful pain reduction in patients with complex regional pain syndrome type 1?, Clin J Pain, 19, 281, 10.1097/00002508-200309000-00001 Frost, 2002, Patient, clinician, and population perspectives on determining the clinical significance of quality of life scores, Mayo Clin Proc, 77, 488, 10.1016/S0025-6196(11)62219-2 Gallagher, 2002, Reliability and validity of a Visual Analog Scale for acute abdominal pain in the ED, Am J Emerg Med, 20, 287, 10.1053/ajem.2002.33778 Gallagher, 2001, Prospective validation of clinically important changes in pain severity measured on a visual analog scale, Ann Emerg Med, 38, 633, 10.1067/mem.2001.118863 Geisser, 1997, Assessing depression among persons with chronic pain using the Center for Epidemiological Studies—Depression Scale and the Beck Depression Inventory: A comparative analysis, Clin J Pain, 13, 163, 10.1097/00002508-199706000-00011 Geurts, 2003, Radiofrequency lesioning of dorsal root ganglia for chronic lumbosacral radicular pain: A randomized, double-blind, controlled trial, Lancet, 361, 21, 10.1016/S0140-6736(03)12115-0 Greco, 2003, Adaptation to chronic pain in systemic lupus erythematosus: Applicability of the Multidimensional Pain Inventory, Pain Med, 4, 39, 10.1046/j.1526-4637.2003.03001.x Guy, 1976 Guyatt, 2000, Making sense of quality-of-life data, Med Care, 38, II-175 Guyatt, 2002, A critical look at transition ratings, J Clin Epidemiol, 55, 900, 10.1016/S0895-4356(02)00435-3 Guyatt, 2002, Methods to explain the clinical significance of health status measures, Mayo Clin Proc, 77, 371, 10.4065/77.4.371 Hägg, 2003, The clinical importance of changes in outcome scores after treatment for chronic low back pain, Eur Spine J, 12, 12, 10.1007/s00586-002-0464-0 Hanley, 2006, Clinically significant changes in pain intensity ratings in persons with spinal cord injury or amputation, Clin J Pain, 22, 25, 10.1097/01.ajp.0000148628.69627.82 Hays, 2000, The concept of clinically meaningful difference in health-related quality-of-life research: How meaningful is it?, Pharmacoeconomics, 18, 419, 10.2165/00019053-200018050-00001 Haythornthwaite Heald, 1997, The shoulder pain and disability index: The construct validity and responsiveness of a region-specific disability measure, Phys Ther, 77, 1079, 10.1093/ptj/77.10.1079 Hoffman, 2007, Meta-analysis of psychological interventions for chronic back pain, Health Psychol, 25, 1, 10.1037/0278-6133.26.1.1 Holdgate, 2003, Comparison of a verbal numeric rating scale with the visual analogue scale for the measurement of acute pain, Emerg Med, 15, 441, 10.1046/j.1442-2026.2003.00499.x Huff, 1954 Huse, 2001, The effect of opioids on phantom limb pain and cortical reorganization, Pain, 90, 47, 10.1016/S0304-3959(00)00385-7 Jacobson, 1999, Methods for defining and determining the clinical significance of treatment effects: Description, application, and alternatives, J Consult Clin Psychol, 67, 300, 10.1037/0022-006X.67.3.300 Jaeschke, 1989, Measurement of health status: Ascertaining the minimal clinically important difference, Control Clin Trials, 10, 407, 10.1016/0197-2456(89)90005-6 Jenkins, 1976, Tofranil in the treatment of low back pain, J Int Med Res, 4, 28 Jensen, 2003, Interpretation of visual analog scale ratings and change scores: A reanalysis of two clinical trials of postoperative pain, J Pain, 4, 407, 10.1016/S1526-5900(03)00716-8 Jensen, 1994, Correlates of improvement in multidisciplinary treatment of chronic pain, J Consult Clin Psychol, 62, 172, 10.1037/0022-006X.62.1.172 Johansson, 2000, Low back pain patients in primary care: Subgroups based on the Multidimensional Pain Inventory, Int J Behav Med, 7, 340, 10.1207/S15327558IJBM0704_05 Johansson, 1998, Effects of a cognitive-behavioral pain-management program, Behav Res Ther, 36, 915, 10.1016/S0005-7967(98)00079-5 Juniper, 1994, Determining a minimal important change in a disease-specific quality of life questionnaire, J Clin Epidemiol, 47, 81, 10.1016/0895-4356(94)90036-1 Kazdin, 1999, The meanings and measurement of clinical significance, J Consult Clin Psychol, 67, 332, 10.1037/0022-006X.67.3.332 Kazis, 1989, Effect sizes for interpreting changes in health status, Med Care, 27, S178, 10.1097/00005650-198903001-00015 Kelly, 1998, Does the clinically significant difference in visual analog scale pain scores vary with gender, age, or cause of pain?, Acad Emerg Med, 5, 1086, 10.1111/j.1553-2712.1998.tb02667.x Kelly, 2001, The minimum clinically significant difference in visual analogue scale pain score does not differ with severity of pain, Emerg Med J, 18, 205, 10.1136/emj.18.3.205 Kerns Kerns, 1985, The West Haven-Yale Multidimensional Pain Inventory (WHYMPI), Pain, 23, 345, 10.1016/0304-3959(85)90004-1 King, 2002, Predictors of success of intervention programs for persons with fibromyalgia, J Rheumatol, 29, 1034 Kosinski, 2000, Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis, Arthritis Rheum, 43, 1478, 10.1002/1529-0131(200007)43:7<1478::AID-ANR10>3.0.CO;2-M Kraemer, 2003, Measures of clinical significance, J Am Acad Child Adolesc Psychiatry, 42, 1524, 10.1097/00004583-200312000-00022 Lai, 2003, Can an item response theory–based pain item bank enhance measurement precision?, Clin Ther, 25, D34, 10.1016/S0149-2918(03)80267-9 Lin, 2003, Effect of cancer pain on performance status, mood states, and level of hope among Taiwanese cancer patients, J Pain Symptom Manage, 25, 29, 10.1016/S0885-3924(02)00542-0 Lipscomb, 2002, The outcomes of cancer outcomes research: Focusing on the National Cancer Institute’s quality-of-care initiative, Med Care, 40, III3, 10.1097/00005650-200206001-00002 Lousberg, 1999, Psychometric properties of the Multidimensional Pain Inventory, Dutch Language version (MPI-DLV), Behav Res Ther, 37, 167, 10.1016/S0005-7967(98)00137-5 Lydick, 1993, Interpretation of quality of life changes, Qual Life Res, 2, 221, 10.1007/BF00435226 Man-Son-Hing, 2002, Determination of the clinical importance of study results: A review, J Gen Intern Med, 17, 469, 10.1046/j.1525-1497.2002.11111.x Marhold, 2001, A cognitive-behavioral return-to-work program: Effects on pain patients with a history of long-term versus short-term sick leave, Pain, 91, 155, 10.1016/S0304-3959(00)00431-0 McNair, 1992 McQuay, 1998 Mendoza, 2006, Reliability and validity of a modified Brief Pain Inventory short form in patients with osteoarthritis, Eur J Pain, 10, 353, 10.1016/j.ejpain.2005.06.002 Miller, 1956, The magical number seven, plus or minus two: Some limits on our capacity for processing information, Psychol Rev, 63, 81, 10.1037/h0043158 Montoya, 2005, Abnormal affective modulation of somatosensory brain processing among patients with fibromyalgia, Psychosom Med, 67, 957, 10.1097/01.psy.0000188401.55394.18 Moore, 1998, Size is everything: Large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects, Pain, 78, 209, 10.1016/S0304-3959(98)00140-7 Morley, 1999, Systematic review and meta-analysis of randomized controlled trails of cognitive behavior therapy and behavior therapy for chronic pain in adults, excluding headache, Pain, 80, 1, 10.1016/S0304-3959(98)00255-3 Morley, 2002, A confirmatory factor analysis of the Beck Depression Inventory in chronic pain, Pain, 99, 289, 10.1016/S0304-3959(02)00137-9 Nicholas, 1991, Operant-behavioral and cognitive-behavioral treatment for chronic low back pain, Pain, 48, 339, 10.1016/0304-3959(92)90082-M Norman, 2003, Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation, Med Care, 41, 582, 10.1097/01.MLR.0000062554.74615.4C Norman, 1997, Methodological problems in the retrospective computation of responsiveness to change: The lessons of Cronbach, J Clin Epidemiol, 50, 869, 10.1016/S0895-4356(97)00097-8 Nunnally, 1994 Osborne, 2006, The reliability and validity of pain interference measures in persons with multiple sclerosis, J Pain Symptom Manage, 32, 217, 10.1016/j.jpainsymman.2006.03.008 Pincus, 2005, Continuous indices of core data set measures in rheumatoid arthritis clinical trials, Arthritis Rheum, 52, 1031, 10.1002/art.20995 Raichle, 2006, The reliability and validity of pain interference measures in persons with spinal cord injury, J Pain, 7, 179, 10.1016/j.jpain.2005.10.007 Redelmeier, 1997, Interpreting small differences in functional status: The Six Minute Walk test in chronic lung disease patients, Am J Respir Crit Care Med, 155, 1278, 10.1164/ajrccm.155.4.9105067 Redelmeier, 1996, Spirometry and dyspnea in patients with COPD, Chest, 109, 1163, 10.1378/chest.109.5.1163 Redelmeier, 1996, Assessing the minimal important difference in symptoms: A comparison of two techniques, J Clin Epidemiol, 49, 1215, 10.1016/S0895-4356(96)00206-5 Reitsma, 1997, Pain and patienthood, Clin J Pain, 13, 9, 10.1097/00002508-199703000-00004 Revicki, 2006, Responsiveness and minimal important differences for patient reported outcomes, Health Qual Life Outcomes, 4, 70, 10.1186/1477-7525-4-70 Robinson, 2005, Multidimensional success criteria and expectations for treatment of chronic pain: The patient perspective, Pain Med, 6, 336, 10.1111/j.1526-4637.2005.00059.x Roland, 1983, A study of the natural history of back pain, part I: Development of a reliable and sensitive measure of disability in low-back pain, Spine, 8, 141, 10.1097/00007632-198303000-00004 Ross, 1989, Relation of implicit theories to the construction of personal histories, Psychol Rev, 96, 341, 10.1037/0033-295X.96.2.341 Rowbotham, 1998, Gabapentin for the treatment of postherpetic neuralgia: A randomized controlled trial, JAMA, 280, 1837, 10.1001/jama.280.21.1837 Rowbotham, 2003, Oral opioid therapy for chronic peripheral and central neuropathic pain, N Engl J Med, 348, 1223, 10.1056/NEJMoa021420 Rudy, 1987 Ruta, 1994, A new approach to the measurement of quality of life: The Patient Generated Index, Med Care, 32, 1109, 10.1097/00005650-199411000-00004 Ruta, 1999, Patient centered assessment of quality of life for patients with four common conditions, Qual Health Care, 8, 22, 10.1136/qshc.8.1.22 Salaffi, 2004, Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale, Eur J Pain, 283, 10.1016/j.ejpain.2003.09.004 Sator-Katzenschlager, 2003, Does pain relief improve pain behavior and mood in chronic pain patients?, Anesth Analg, 97, 791, 10.1213/01.ANE.0000078584.03856.D3 Scharff, 1995, Psychosocial and behavioral characteristics in chronic headache patients: Support for a continuum and dual-diagnostic approach, Cephalalgia, 15, 216, 10.1046/j.1468-2982.1995.015003216.x Schwartz, 2002, Measurement of fatigue: Determining minimally important clinical differences, J Clin Epidemiol, 55, 239, 10.1016/S0895-4356(01)00469-3 Serlin, 1995, When is cancer pain mild, moderate or severe?, Pain, 61, 277, 10.1016/0304-3959(94)00178-H Slater, 1997, The clinical significance of behavioral treatment for chronic low back pain: An evaluation of effectiveness, Pain, 71, 257, 10.1016/S0304-3959(97)03374-5 Sloan, 2005, Clinical significance of patient-reported questionnaire data: Another step toward consensus, J Clin Epidemiol, 58, 1217, 10.1016/j.jclinepi.2005.07.009 Sloan, 2003, Practical guidelines for assessing the clinical significance of health-related quality of life changes within clinical trials, Drug Inf J, 37, 23, 10.1177/009286150303700105 Smith, 1993, Effects of present pain level on recall of chronic pain and medication use, Pain, 55, 355, 10.1016/0304-3959(93)90011-D Smith, 1998, The meaning of pain: Cancer patients’ rating and recall of pain intensity and affect, Pain, 78, 123, 10.1016/S0304-3959(98)00122-5 Speca, 2000, A randomized, wait-list controlled clinical trial: The effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients, Psychosom Med, 62, 613, 10.1097/00006842-200009000-00004 Sterner, 2001, Early interdisciplinary rehabilitation programme for whiplash associated disorders, Disabil Rehabil, 23, 422, 10.1080/09638280010008852 Stratford, 1996, Defining the minimal level of detectable change for the Roland Morris questionnaire, Phys Ther, 76, 359, 10.1093/ptj/76.4.359 Stucki, 1996, Interpretation of change scores in ordinal clinical scales and health status measures: The whole may not equal the sum of the parts, J Clin Epidemiol, 49, 711, 10.1016/0895-4356(96)00016-9 Symonds, 2002, The clinical significance of quality-of-life results: Practical considerations for specific audiences, Mayo Clin Proc, 77, 572, 10.4065/77.6.572 ten Klooster, 2006, Patient-perceived satisfactory improvement (PPSI): Interpreting meaningful change in pain from the patient’s perspective, Pain, 121, 151, 10.1016/j.pain.2005.12.021 Testa, 2000, Interpretation of quality-of-life outcomes: issues that affect magnitude and meaning, Med Care, 38, II-166 Thieme, 2003, Operant behavioral treatment of fibromyalgia: A controlled study, Arthritis Care Res, 49, 314, 10.1002/art.11124 Todd, 1996, Clinical significance of reported changes in pain severity, Ann Emerg Med, 27, 485, 10.1016/S0196-0644(96)70238-X Todd, 2001, Patient-oriented outcome measures: The promise of definition, Ann Emerg Med, 38, 672, 10.1067/mem.2001.119746 Tubach, 2006, Feeling good rather than feeling better matters more to patients, Arthritis Rheum, 55, 526, 10.1002/art.22110 Tubach, 2005, Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: The patient acceptable symptom state, Ann Rheum Dis, 64, 34, 10.1136/ard.2004.023028 Turk Turk, 2003, Core outcome domains for chronic pain clinical trials: IMMPACT recommendations, Pain, 106, 337, 10.1016/j.pain.2003.08.001 Turk, 2006, Developing outcome measures for pain clinical trials: IMMPACT recommendations, Pain, 125, 208, 10.1016/j.pain.2006.09.028 Turk, 1996, Pain, disability, and physical functioning in subgroups of fibromyalgia patients, J Rheumatology, 23, 1255 Turk, 1990, Robustness of an empirically derived taxonomy of chronic pain patients, Pain, 43, 27, 10.1016/0304-3959(90)90047-H Turk, 1998, Adaptation to metastatic cancer pain, regional/local cancer pain, and non-cancer pain: Role of psychological and behavioral factors, Pain, 73, 247, 10.1016/S0304-3959(97)00187-5 Turner-Stokes, 2003, Outpatient cognitive-behavioral pain management programs: A randomized comparison of a group-based multidisciplinary versus an individual therapy model, Arch Phys Med Rehabil, 84, 781, 10.1016/S0003-9993(03)00015-7 Van Kleef, 1996, Radiofrequency lesion adjacent to the dorsal root ganglion for cervicobrachial pain: A prospective double blind randomized study, Neurosurgery, 38, 1127 Vlaeyen, 1995, Behavioural rehabilitation of chronic low back pain: Comparison of an operant treatment, an operant-cognitive treatment, and an operant-respondent treatment, Br J Clin Psychol, 34, 95, 10.1111/j.2044-8260.1995.tb01443.x Weiner, 2003, Efficacy of percutaneous electrical nerve stimulation for the treatment of chronic low back pain in older adults, J Am Geriatr Soc, 51, 599, 10.1034/j.1600-0579.2003.00202.x Wells, 2001, Minimal clinically important differences: Review of methods, J Rheumatol, 28, 406 Wells, 2006, Low disease activity state in rheumatoid arthritis: Concepts and derivation of minimal disease activity, Clin Exp Rheumatol, 24, S52 Wells, 1993, Minimum important difference between patients with rheumatoid arthritis: The patient’s perspective, J Rheumatol, 20, 557 Wernicke, 2006, A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain, Neurology, 67, 1411, 10.1212/01.wnl.0000240225.04000.1a Widar, 1999, Pain in persons with post-polio: The Swedish version of the Multidimensional Pain Inventory (MPI), Scand J Caring Sci, 13, 33 Wolinsky, 1998, Changes in the SF-36 in 12 months in a clinical sample of disadvantaged older adults, Med Care, 36, 1589, 10.1097/00005650-199811000-00008 Wright, 2003, Interpreting health-related quality of life scores: The simple rule of seven may not be so simple, Med Care, 41, 597, 10.1097/00005650-200305000-00006 Wyrwich, 2005, Estimating clinically significant differences in quality of life outcomes, Qual Life Res, 14, 285, 10.1007/s11136-004-0705-2 Wyrwich, 2003, Clinically important changes in health-related quality of life for patients with chronic obstructive pulmonary disease: An expert consensus panel report, J Gen Intern Med, 18, 196, 10.1046/j.1525-1497.2003.20203.x Wyrwich, 1999, Linking clinical relevance and statistical significance in evaluating intra-individual changes in health related quality of life, Med Care, 37, 469, 10.1097/00005650-199905000-00006 Wyrwich, 1999, Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life, J Clin Epidemiol, 52, 861, 10.1016/S0895-4356(99)00071-2 Wyrwich, 2000, Identifying meaningful intra-individual change standards for health-related quality of life measures, J Eval Clin Pract, 6, 39, 10.1046/j.1365-2753.2000.00238.x Yost, 2005, Minimally important differences were estimated for the Functional Assessment of Cancer Therapy—Colorectal (FACT-C) instrument using a combination of distribution- and anchor-based approaches, J Clin Epidemiol, 58, 1241, 10.1016/j.jclinepi.2005.07.008